Cuproptosis-Related lncRNA Predict Prognosis and Immune Response of LUAD
Article in Pharmacogenomics and Personalized Medicine (June 2024)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
A disulfidptosis-related lncRNA signature for predicting prognosis and evaluating the tumor immune microenvironment of lung adenocarcinoma
Article in Scientific Reports (February 2024)
Integrating bioinformatics and experimental validation to unveil disulfidptosis-related lncRNAs as prognostic biomarker and therapeutic target in hepatocellular carcinoma
Article in Cancer Cell International (January 2024)